TO THE EDITOR: Schinzari et al. (4) compared the endothelialdependent and -independent vasodilatory responses in controls and subjects with metabolic syndrome (MetSyn). The primary objective was to explore the integrity of the nitric oxide (NO) pathway and evaluate the effects of hyperinsulinemia on blood flow in subjects with different insulin sensitivity.
suggest that in basal conditions the endothelial-dependent response was impaired in subjects with MetSyn, whereas the endothelial-independent vascular response was preserved. A more robust statistical analysis could have been conducted by entering both the diagnostic (control vs. MetSyn) and the insulin level group (basal vs. high) in the model as fixed factors and building an interaction term to compare the time-related vascular responses for each pharmacological agent. This would have shown whether there was any difference in vascular reactivity between the diagnostic and the insulin level groups.
Why are vascular responses to hyperinsulinemia different between groups? Insulin stimulates endothelial NO production via an Akt-dependent activation of the endothelial NO synthase (3). Compromised insulin signaling, therefore, reduces NO synthesis and impairs vasodilatation, which is probably contributing to the differences in vascular reactivity seen during hyperinsulinemia (2). The authors also suggest that insulin could have local vasodilatory effects on the vascular smooth muscle cells via modifications of calcium influx (4). However, the transcapillary (or transendothelial) transfer of insulin in the interstitium was not taken into account in this hypothesis. As the process is rate limiting (1), it still depends on the integrity of the endothelial cells, and it is delayed in obese insulinresistant subjects (5). Therefore, it could be speculated that the rate and amount of insulin delivered into the interstitial space may be coresponsible for the lack of vasodilatory effects of insulin in subjects with MetSyn.
A between-group comparison of the vascular responses in the basal and hyperinsulinemic states should be conducted to confirm the generalized impairment in vascular reactivity in the obese group with MetSyn.
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